<i>Citrus aurantium</i> Naringenin Prevents Osteosarcoma Progression and Recurrence in the Patients Who Underwent Osteosarcoma Surgery by Improving Antioxidant Capability

<div>Serum ROS levels of osteosarcoma patients. CG-B, the patients before receiving placebo treatment. NG-B, the patients before receiving naringenin treatment. CG-A, the patients after receiving two-year placebo treatment. NG-B, the patients after receiving two-year naringenin treatment.</div>

Oxidative Medicine and Cellular Longevity

fig7

Figure 7

Figure 7: <i>Citrus aurantium</i> Naringenin Prevents Osteosarcoma Progression and Recurrence in the Patients Who Underwent Osteosarcoma Surgery by Improving Antioxidant Capability 

Figure 7 | Citrus aurantium Naringenin Prevents Osteosarcoma Progression and Recurrence in the Patients Who Underwent Osteosarcoma Surgery by Improving Antioxidant Capability 